speb/financial-data huggingface dataset:
THC cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -32000000.00
THC cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -348000000.00
THC income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 19000000.00
THC balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3414000000.00
THC income_statement (quarterly, 2025-03-31) — Salaries And Wages: 2119000000.00
THC cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 14000000.00
THC cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 11000000.00
THC income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2119000000.00
THC balance_sheet (quarterly, 2025-03-31) — Share Issued: 158405000.00
THC income_statement (quarterly, 2025-03-31) — Special Income Charges: -14000000.00
THC cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 21000000.00
THC balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4181000000.00
THC balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -8005000000.00
THC income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -2618000.00
THC income_statement (quarterly, 2025-03-31) — Tax Provision: 143000000.00
THC income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.19
THC balance_sheet (quarterly, 2025-03-31) — Total Assets: 29237000000.00
THC balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 17263000000.00
THC balance_sheet (quarterly, 2025-03-31) — Total Debt: 13170000000.00
THC balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 8653000000.00
THC income_statement (quarterly, 2025-03-31) — Total Expenses: 4322000000.00
THC balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 20584000000.00
THC balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 21324000000.00
THC balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 16133000000.00
THC income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 943000000.00
THC balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 149000000.00
THC income_statement (quarterly, 2025-03-31) — Total Unusual Items: -14000000.00
THC income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -14000000.00
THC balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 65520000.00
THC balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 3889000000.00
THC balance_sheet (quarterly, 2025-03-31) — Working Capital: 3462000000.00
THC income_statement (quarterly, 2025-06-30) — +Operating Expense: 3487000000.00
THC income_statement (quarterly, 2025-06-30) — +Total Revenue: 5271000000.00
THC balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1360000000.00
THC balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2533000000.00
THC balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -6096000000.00
THC balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 4858000000.00
THC cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 3000000.00
THC balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 21000000.00
THC income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: 0.00
THC income_statement (quarterly, 2025-06-30) — Basic Average Shares: 91135000.00
THC income_statement (quarterly, 2025-06-30) — Basic EPS: 3.16
THC cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2999000000.00
THC cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -193000000.00
THC balance_sheet (quarterly, 2025-06-30) — Capital Stock: 8000000.00
THC balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2625000000.00
THC balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2625000000.00
THC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -996000000.00
THC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -314000000.00
THC cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 936000000.00
THC cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 0.00
THC cash_flow (quarterly, 2025-06-30) — Change In Inventory: 117000000.00
THC cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 40000000.00
THC cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -122000000.00
THC cash_flow (quarterly, 2025-06-30) — Change In Payable: 0.00
THC cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 0.00
THC cash_flow (quarterly, 2025-06-30) — Change In Receivables: 109000000.00
THC cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 144000000.00
THC cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 109000000.00
THC cash_flow (quarterly, 2025-06-30) — Changes In Cash: -374000000.00
THC balance_sheet (quarterly, 2025-06-30) — Common Stock: 8000000.00
THC balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3749000000.00
THC cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -747000000.00
THC income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 932000000.00
THC balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 148000000.00
THC balance_sheet (quarterly, 2025-06-30) — Current Assets: 7298000000.00
THC balance_sheet (quarterly, 2025-06-30) — Current Debt: 84000000.00
THC balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 84000000.00
THC balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4271000000.00
THC balance_sheet (quarterly, 2025-06-30) — Current Provisions: 275000000.00
THC cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 7000000.00
THC cash_flow (quarterly, 2025-06-30) — Deferred Tax: 7000000.00
THC cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 208000000.00
THC income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 208000000.00
THC cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 208000000.00
THC income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 208000000.00
THC income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 91791000.00
THC income_statement (quarterly, 2025-06-30) — Diluted EPS: 3.14
THC income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 288000000.00
THC income_statement (quarterly, 2025-06-30) — EBIT: 848000000.00
THC income_statement (quarterly, 2025-06-30) — EBITDA: 1056000000.00
THC income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 61000000.00
THC cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -13000000.00
THC balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 297000000.00
THC cash_flow (quarterly, 2025-06-30) — End Cash Position: 2625000000.00
THC cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -996000000.00
THC cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 743000000.00
THC cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 38000000.00
THC income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: -38000000.00
THC balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -177000000.00
THC income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2160000000.00
THC balance_sheet (quarterly, 2025-06-30) — Goodwill: 10935000000.00
THC balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 12307000000.00
THC balance_sheet (quarterly, 2025-06-30) — Gross PPE: 12120000000.00
THC income_statement (quarterly, 2025-06-30) — Gross Profit: 4339000000.00
THC cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 235000000.00
THC balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 25000000.00
THC income_statement (quarterly, 2025-06-30) — Interest Expense: 206000000.00
THC income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 206000000.00
THC cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 300000000.00
THC balance_sheet (quarterly, 2025-06-30) — Interest Payable: 148000000.00
THC balance_sheet (quarterly, 2025-06-30) — Inventory: 338000000.00
THC balance_sheet (quarterly, 2025-06-30) — Invested Capital: 16924000000.00
THC cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -314000000.00
THC cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 14000000.00
THC balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 13091000000.00
THC balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 13091000000.00
THC cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 14000000.00
THC cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -30000000.00
THC balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 873000000.00
THC balance_sheet (quarterly, 2025-06-30) — Minority Interest: 4553000000.00
THC income_statement (quarterly, 2025-06-30) — Minority Interests: -234000000.00
THC cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -120000000.00
THC cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -747000000.00
THC balance_sheet (quarterly, 2025-06-30) — Net Debt: 10550000000.00
THC income_statement (quarterly, 2025-06-30) — Net Income: 288000000.00
THC income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 288000000.00
THC income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 522000000.00
THC income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 288000000.00
THC income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 288000000.00
THC cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 522000000.00
THC income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 522000000.00
THC income_statement (quarterly, 2025-06-30) — Net Interest Income: -206000000.00
THC cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 2000000.00
THC cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -16000000.00
THC cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -16000000.00
THC income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -206000000.00
THC cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -233000000.00
THC cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -6000000.00
THC balance_sheet (quarterly, 2025-06-30) — Net PPE: 6024000000.00
THC cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -190000000.00
THC balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -8558000000.00
THC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 76000000.00
THC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 230000000.00
THC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 76000000.00
THC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 230000000.00
THC balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 297000000.00
THC income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1146000000.00
THC income_statement (quarterly, 2025-06-30) — Normalized Income: 361177570.09
THC cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 936000000.00
THC cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 25000000.00
THC income_statement (quarterly, 2025-06-30) — Operating Income: 852000000.00
THC income_statement (quarterly, 2025-06-30) — Operating Revenue: 5271000000.00
THC balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 88344000.00
THC balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 251000000.00
THC balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1586000000.00
THC balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -177000000.00
THC income_statement (quarterly, 2025-06-30) — Other Income Expense: -4000000.00
THC balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1372000000.00
THC cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 7000000.00
THC balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2994000000.00
THC balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1635000000.00
THC income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 25000000.00
THC income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1119000000.00
THC balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1168000000.00
THC income_statement (quarterly, 2025-06-30) — Other Special Charges: 28000000.00
THC balance_sheet (quarterly, 2025-06-30) — Payables: 1385000000.00
THC balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1533000000.00
THC balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 793000000.00
THC balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 362000000.00
THC income_statement (quarterly, 2025-06-30) — Pretax Income: 642000000.00
THC cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -120000000.00
THC cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -21000000.00
THC cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -193000000.00
THC balance_sheet (quarterly, 2025-06-30) — Raw Materials: 338000000.00
THC balance_sheet (quarterly, 2025-06-30) — Receivables: 3701000000.00
THC income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 932000000.00
THC income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 208000000.00
THC cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -30000000.00
THC cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -747000000.00
THC income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 21000000.00
THC balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 3702000000.00
THC income_statement (quarterly, 2025-06-30) — Salaries And Wages: 2160000000.00
THC cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 23000000.00
THC cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 3000000.00
THC income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2160000000.00
THC balance_sheet (quarterly, 2025-06-30) — Share Issued: 158465000.00
THC income_statement (quarterly, 2025-06-30) — Special Income Charges: -90000000.00
THC cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 20000000.00
THC balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3749000000.00
THC balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -8558000000.00
THC income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -16822429.91
THC income_statement (quarterly, 2025-06-30) — Tax Provision: 120000000.00
THC income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.19
THC balance_sheet (quarterly, 2025-06-30) — Total Assets: 28699000000.00
THC balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 16840000000.00
THC balance_sheet (quarterly, 2025-06-30) — Total Debt: 13175000000.00
THC balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 8302000000.00
THC income_statement (quarterly, 2025-06-30) — Total Expenses: 4419000000.00
THC balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 20397000000.00
THC balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 21401000000.00
THC balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 16126000000.00
THC income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 823000000.00
THC balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 25000000.00
THC income_statement (quarterly, 2025-06-30) — Total Unusual Items: -90000000.00
THC income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -90000000.00
THC balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 70121000.00
THC balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 4642000000.00
THC balance_sheet (quarterly, 2025-06-30) — Working Capital: 3027000000.00
THC income_statement (quarterly, 2025-06-30) — Write Off: 3000000.00
THC income_statement (quarterly, 2025-09-30) — +Operating Expense: 3541000000.00
THC income_statement (quarterly, 2025-09-30) — +Total Revenue: 5289000000.00
THC balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1356000000.00
THC balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2518000000.00
THC balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -6196000000.00
THC balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 4872000000.00
THC cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 63000000.00
THC balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 82000000.00
THC income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 0.00
THC income_statement (quarterly, 2025-09-30) — Basic Average Shares: 87951000.00
THC income_statement (quarterly, 2025-09-30) — Basic EPS: 3.89
THC cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2625000000.00
THC cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -280000000.00
THC balance_sheet (quarterly, 2025-09-30) — Capital Stock: 8000000.00
THC balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2975000000.00
THC balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2975000000.00
THC cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -323000000.00
THC cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -385000000.00
THC cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1058000000.00
THC cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 213000000.00
THC cash_flow (quarterly, 2025-09-30) — Change In Inventory: -67000000.00
THC cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 18000000.00
THC cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 5000000.00
THC cash_flow (quarterly, 2025-09-30) — Change In Payable: 213000000.00
THC cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 213000000.00
THC cash_flow (quarterly, 2025-09-30) — Change In Receivables: 28000000.00
THC cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 197000000.00
THC cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 28000000.00
THC cash_flow (quarterly, 2025-09-30) — Changes In Cash: 350000000.00
THC balance_sheet (quarterly, 2025-09-30) — Common Stock: 8000000.00
THC balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4014000000.00
THC cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -93000000.00
THC income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 931000000.00
THC balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 248000000.00
THC balance_sheet (quarterly, 2025-09-30) — Current Assets: 7810000000.00
THC balance_sheet (quarterly, 2025-09-30) — Current Debt: 85000000.00
THC balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 85000000.00
THC balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4560000000.00
THC balance_sheet (quarterly, 2025-09-30) — Current Provisions: 287000000.00
THC cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 40000000.00
THC cash_flow (quarterly, 2025-09-30) — Deferred Tax: 40000000.00
THC cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 218000000.00
THC income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 218000000.00
THC cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 218000000.00
THC income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 218000000.00
THC income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 88610000.00
THC income_statement (quarterly, 2025-09-30) — Diluted EPS: 3.86
THC income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 342000000.00
THC income_statement (quarterly, 2025-09-30) — EBIT: 918000000.00
THC income_statement (quarterly, 2025-09-30) — EBITDA: 1136000000.00
THC income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 64000000.00
THC cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -5000000.00
THC balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 296000000.00
THC cash_flow (quarterly, 2025-09-30) — End Cash Position: 2975000000.00
THC cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -323000000.00
THC cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 778000000.00
THC cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -20000000.00
THC income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: 20000000.00
THC balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -174000000.00
THC income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2204000000.00
THC balance_sheet (quarterly, 2025-09-30) — Goodwill: 11158000000.00
THC balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 12506000000.00
THC balance_sheet (quarterly, 2025-09-30) — Gross PPE: 12287000000.00
THC income_statement (quarterly, 2025-09-30) — Gross Profit: 4358000000.00
THC cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 87000000.00
THC balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 28000000.00
THC income_statement (quarterly, 2025-09-30) — Interest Expense: 206000000.00
THC income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 206000000.00
THC cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 100000000.00
THC balance_sheet (quarterly, 2025-09-30) — Interest Payable: 248000000.00
THC balance_sheet (quarterly, 2025-09-30) — Inventory: 346000000.00
THC balance_sheet (quarterly, 2025-09-30) — Invested Capital: 17201000000.00
THC cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -385000000.00
THC cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 6000000.00
THC balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 13102000000.00
THC balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 13102000000.00
THC cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 6000000.00
THC cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -28000000.00
THC balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 891000000.00
THC balance_sheet (quarterly, 2025-09-30) — Minority Interest: 4686000000.00
THC income_statement (quarterly, 2025-09-30) — Minority Interests: -237000000.00
THC cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -119000000.00
THC cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -93000000.00
THC balance_sheet (quarterly, 2025-09-30) — Net Debt: 10212000000.00
THC income_statement (quarterly, 2025-09-30) — Net Income: 342000000.00
THC income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 342000000.00
THC income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 579000000.00
THC income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 342000000.00
THC income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 342000000.00
THC cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 579000000.00
THC income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 579000000.00
THC income_statement (quarterly, 2025-09-30) — Net Interest Income: -206000000.00
THC cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 6000000.00
THC cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -22000000.00
THC cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -22000000.00
THC income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -206000000.00
THC cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -208000000.00
THC cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 4000000.00
THC balance_sheet (quarterly, 2025-09-30) — Net PPE: 6091000000.00
THC cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -276000000.00
THC balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -8492000000.00
THC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 72000000.00
THC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 269000000.00
THC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 72000000.00
THC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 269000000.00
THC balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 296000000.00
THC income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1128000000.00
THC income_statement (quarterly, 2025-09-30) — Normalized Income: 335494382.02
THC cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1058000000.00
THC cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -27000000.00
THC income_statement (quarterly, 2025-09-30) — Operating Income: 817000000.00
THC income_statement (quarterly, 2025-09-30) — Operating Revenue: 5289000000.00
THC balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 87867000.00
THC balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 256000000.00
THC balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1699000000.00
THC balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -174000000.00
THC income_statement (quarterly, 2025-09-30) — Other Income Expense: 101000000.00
THC balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1348000000.00
THC cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -50000000.00
THC balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2939000000.00
THC balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1600000000.00
THC income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 29000000.00
THC income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1119000000.00
THC balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1260000000.00
THC income_statement (quarterly, 2025-09-30) — Other Special Charges: -11000000.00
THC balance_sheet (quarterly, 2025-09-30) — Payables: 1384000000.00
THC balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1632000000.00
THC balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 857000000.00
THC balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 373000000.00
THC income_statement (quarterly, 2025-09-30) — Pretax Income: 712000000.00
THC cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -119000000.00
THC cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -31000000.00
THC cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -280000000.00
THC balance_sheet (quarterly, 2025-09-30) — Raw Materials: 346000000.00
THC balance_sheet (quarterly, 2025-09-30) — Receivables: 3778000000.00
THC income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 931000000.00
THC income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 218000000.00
THC cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -28000000.00
THC cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -93000000.00
THC income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 13000000.00
THC balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 4044000000.00
THC income_statement (quarterly, 2025-09-30) — Salaries And Wages: 2204000000.00
THC cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 37000000.00
THC cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 4000000.00
THC income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2204000000.00
THC balance_sheet (quarterly, 2025-09-30) — Share Issued: 158585000.00
THC income_statement (quarterly, 2025-09-30) — Special Income Charges: 8000000.00
THC cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 38000000.00
THC balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4014000000.00
THC balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -8492000000.00
THC income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 1494382.02
THC income_statement (quarterly, 2025-09-30) — Tax Provision: 133000000.00
THC income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.19
THC balance_sheet (quarterly, 2025-09-30) — Total Assets: 29418000000.00
THC balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 17116000000.00
THC balance_sheet (quarterly, 2025-09-30) — Total Debt: 13187000000.00
THC balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 8700000000.00
THC income_statement (quarterly, 2025-09-30) — Total Expenses: 4472000000.00
THC balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 20718000000.00
THC balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 21608000000.00
THC balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 16158000000.00
THC income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 889000000.00
THC balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 28000000.00
THC income_statement (quarterly, 2025-09-30) — Total Unusual Items: 8000000.00
THC income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 8000000.00
THC balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 70718000.00
THC balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 4736000000.00
THC balance_sheet (quarterly, 2025-09-30) — Working Capital: 3250000000.00
THC income_statement (quarterly, 2025-09-30) — Write Off: 10000000.00
THC income_statement (annual, 2025-12-31) — +Operating Expense: 14091000000.00
THC income_statement (quarterly, 2025-12-31) — +Operating Expense: 3648000000.00
THC income_statement (annual, 2025-12-31) — +Total Revenue: 21310000000.00
THC income_statement (quarterly, 2025-12-31) — +Total Revenue: 5527000000.00
THC balance_sheet (annual, 2025-12-31) — Accounts Payable: 1360000000.00
THC balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1360000000.00
THC balance_sheet (annual, 2025-12-31) — Accounts Receivable: 2565000000.00
THC balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2565000000.00
THC balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -6680000000.00
THC balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -6680000000.00
THC balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4914000000.00
THC balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4914000000.00
THC cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 166000000.00
THC cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 166000000.00
THC cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 61000000.00
THC cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: -5000000.00
THC balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 62000000.00
THC balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 62000000.00
THC balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 59000000.00
THC balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 59000000.00
THC income_statement (annual, 2025-12-31) — Average Dilution Earnings: 0.00
THC income_statement (quarterly, 2025-12-31) — Average Dilution Earnings: 0.00
THC income_statement (annual, 2025-12-31) — Basic Average Shares: 90150000.00
THC income_statement (quarterly, 2025-12-31) — Basic Average Shares: 87271000.00
THC income_statement (annual, 2025-12-31) — Basic EPS: 15.61
THC income_statement (quarterly, 2025-12-31) — Basic EPS: 4.25
THC cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3019000000.00
THC cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 2975000000.00
THC balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 6672000000.00
THC balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 6672000000.00
THC cash_flow (annual, 2025-12-31) — Capital Expenditure: -1010000000.00
THC cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -364000000.00
THC balance_sheet (annual, 2025-12-31) — Capital Stock: 8000000.00
THC balance_sheet (quarterly, 2025-12-31) — Capital Stock: 8000000.00
THC balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2883000000.00
THC balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2883000000.00
THC balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2883000000.00
THC balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2883000000.00
THC cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2401000000.00
THC cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -434000000.00
THC cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1275000000.00
THC cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -389000000.00
THC cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3540000000.00
THC cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 731000000.00
THC cash_flow (annual, 2025-12-31) — Change In Account Payable: 209000000.00
THC cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -28000000.00
THC cash_flow (annual, 2025-12-31) — Change In Inventory: -73000000.00
THC cash_flow (quarterly, 2025-12-31) — Change In Inventory: -15000000.00
THC cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 9000000.00
THC cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -41000000.00
THC cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -25000000.00
THC cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -40000000.00
THC cash_flow (annual, 2025-12-31) — Change In Payable: 209000000.00
THC cash_flow (quarterly, 2025-12-31) — Change In Payable: -28000000.00
THC cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 209000000.00
THC cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -28000000.00
THC cash_flow (annual, 2025-12-31) — Change In Receivables: 20000000.00
THC cash_flow (quarterly, 2025-12-31) — Change In Receivables: -48000000.00
THC cash_flow (annual, 2025-12-31) — Change In Working Capital: 140000000.00
THC cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -172000000.00
THC cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 20000000.00
THC cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -48000000.00
THC cash_flow (annual, 2025-12-31) — Changes In Cash: -136000000.00
THC cash_flow (quarterly, 2025-12-31) — Changes In Cash: -92000000.00
THC balance_sheet (annual, 2025-12-31) — Common Stock: 8000000.00
THC balance_sheet (quarterly, 2025-12-31) — Common Stock: 8000000.00
THC balance_sheet (annual, 2025-12-31) — Common Stock Equity: 4220000000.00
THC balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 4220000000.00
THC cash_flow (annual, 2025-12-31) — Common Stock Payments: -1386000000.00
THC cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -198000000.00
THC balance_sheet (annual, 2025-12-31) — Construction In Progress: 211000000.00
THC balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 211000000.00
THC income_statement (annual, 2025-12-31) — Cost Of Revenue: 3780000000.00
THC income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1010000000.00
THC balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 81000000.00
THC balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 81000000.00
THC balance_sheet (annual, 2025-12-31) — Current Assets: 7849000000.00
THC balance_sheet (quarterly, 2025-12-31) — Current Assets: 7849000000.00
THC balance_sheet (annual, 2025-12-31) — Current Debt: 79000000.00
THC balance_sheet (quarterly, 2025-12-31) — Current Debt: 79000000.00
THC balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 79000000.00
THC balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 79000000.00
THC balance_sheet (annual, 2025-12-31) — Current Liabilities: 4463000000.00
THC balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4463000000.00
THC balance_sheet (annual, 2025-12-31) — Current Provisions: 276000000.00
THC balance_sheet (quarterly, 2025-12-31) — Current Provisions: 276000000.00
THC cash_flow (annual, 2025-12-31) — Deferred Income Tax: 9000000.00
THC cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -42000000.00
THC cash_flow (annual, 2025-12-31) — Deferred Tax: 9000000.00
THC cash_flow (quarterly, 2025-12-31) — Deferred Tax: -42000000.00
THC cash_flow (annual, 2025-12-31) — Depreciation: 697000000.00
THC cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 863000000.00
THC cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 231000000.00
THC income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 863000000.00
THC income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 231000000.00
THC cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 863000000.00
THC cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 231000000.00
THC income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 863000000.00
THC income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 231000000.00
THC income_statement (annual, 2025-12-31) — Diluted Average Shares: 90833000.00
THC income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 87917000.00
THC income_statement (annual, 2025-12-31) — Diluted EPS: 15.49
THC income_statement (quarterly, 2025-12-31) — Diluted EPS: 4.22
THC income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1407000000.00
THC income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 371000000.00
THC income_statement (annual, 2025-12-31) — EBIT: 3621000000.00
THC income_statement (quarterly, 2025-12-31) — EBIT: 886000000.00
THC income_statement (annual, 2025-12-31) — EBITDA: 4484000000.00
THC income_statement (quarterly, 2025-12-31) — EBITDA: 1117000000.00
THC income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 264000000.00
THC income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 83000000.00
THC cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -34000000.00
THC cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -21000000.00
THC balance_sheet (annual, 2025-12-31) — Employee Benefits: 245000000.00
THC balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 245000000.00
THC cash_flow (annual, 2025-12-31) — End Cash Position: 2883000000.00
THC cash_flow (quarterly, 2025-12-31) — End Cash Position: 2883000000.00
THC cash_flow (annual, 2025-12-31) — Financing Cash Flow: -2401000000.00
THC cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -434000000.00
THC cash_flow (annual, 2025-12-31) — Free Cash Flow: 2530000000.00
THC cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 367000000.00
THC cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -4000000.00
THC cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -2000000.00
THC cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 1000000.00
THC cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 5000000.00
THC income_statement (annual, 2025-12-31) — Gain On Sale Of Business: -1000000.00
THC income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: -5000000.00
THC balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -181000000.00
THC balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -181000000.00
THC income_statement (annual, 2025-12-31) — General And Administrative Expense: 8705000000.00
THC income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 2222000000.00
THC balance_sheet (annual, 2025-12-31) — Goodwill: 11198000000.00
THC balance_sheet (quarterly, 2025-12-31) — Goodwill: 11198000000.00
THC balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 12546000000.00
THC balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 12546000000.00
THC balance_sheet (annual, 2025-12-31) — Gross PPE: 14129000000.00
THC balance_sheet (quarterly, 2025-12-31) — Gross PPE: 14129000000.00
THC income_statement (annual, 2025-12-31) — Gross Profit: 17530000000.00
THC income_statement (quarterly, 2025-12-31) — Gross Profit: 4517000000.00
THC income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 61000000.00
THC cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 450000000.00
THC cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 121000000.00
THC balance_sheet (annual, 2025-12-31) — Income Tax Payable: 0.00
THC balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 0.00
THC income_statement (annual, 2025-12-31) — Interest Expense: 821000000.00
THC income_statement (quarterly, 2025-12-31) — Interest Expense: 205000000.00
THC income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 821000000.00
THC income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 205000000.00
THC cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 865000000.00
THC cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 366000000.00
THC balance_sheet (annual, 2025-12-31) — Interest Payable: 81000000.00
THC balance_sheet (quarterly, 2025-12-31) — Interest Payable: 81000000.00
THC balance_sheet (annual, 2025-12-31) — Inventory: 348000000.00
THC balance_sheet (quarterly, 2025-12-31) — Inventory: 348000000.00
THC balance_sheet (annual, 2025-12-31) — Invested Capital: 17391000000.00
THC balance_sheet (quarterly, 2025-12-31) — Invested Capital: 17391000000.00
THC cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1275000000.00
THC cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -389000000.00
THC balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 59000000.00
THC balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 59000000.00
THC balance_sheet (annual, 2025-12-31) — Investments And Advances: 1442000000.00
THC balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 1442000000.00
THC cash_flow (annual, 2025-12-31) — Issuance Of Debt: 2276000000.00
THC cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2255000000.00
THC balance_sheet (annual, 2025-12-31) — Land And Improvements: 534000000.00
THC balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 534000000.00
THC balance_sheet (annual, 2025-12-31) — Long Term Debt: 13092000000.00
THC balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 13092000000.00
THC balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13092000000.00
THC balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13092000000.00
THC cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 2276000000.00
THC cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 2255000000.00
THC cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2372000000.00
THC cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -2282000000.00
THC balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 1383000000.00
THC balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 1383000000.00
THC balance_sheet (annual, 2025-12-31) — Long Term Provisions: 951000000.00
THC balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 951000000.00
THC balance_sheet (annual, 2025-12-31) — Minority Interest: 4753000000.00
THC balance_sheet (quarterly, 2025-12-31) — Minority Interest: 4753000000.00
THC income_statement (annual, 2025-12-31) — Minority Interests: -960000000.00
THC income_statement (quarterly, 2025-12-31) — Minority Interests: -273000000.00
THC cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -308000000.00
THC cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -42000000.00
THC cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -1386000000.00
THC cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -198000000.00
THC balance_sheet (annual, 2025-12-31) — Net Debt: 10288000000.00
THC balance_sheet (quarterly, 2025-12-31) — Net Debt: 10288000000.00
THC income_statement (annual, 2025-12-31) — Net Income: 1407000000.00
THC income_statement (quarterly, 2025-12-31) — Net Income: 371000000.00
THC income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1407000000.00
THC income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 371000000.00
THC income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 2367000000.00
THC income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 644000000.00
THC income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1407000000.00
THC income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 371000000.00
THC income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1407000000.00
THC income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 371000000.00
THC cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 2367000000.00
THC cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 644000000.00
THC income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 2367000000.00
THC income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 644000000.00
THC income_statement (annual, 2025-12-31) — Net Interest Income: -821000000.00
THC income_statement (quarterly, 2025-12-31) — Net Interest Income: -205000000.00
THC cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 3000000.00
THC cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -2000000.00
THC cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -96000000.00
THC cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -27000000.00
THC cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -96000000.00
THC cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -27000000.00
THC income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -821000000.00
THC income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -205000000.00
THC cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -919000000.00
THC cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -209000000.00
THC cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 2000000.00
THC cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -1000000.00
THC balance_sheet (annual, 2025-12-31) — Net PPE: 7449000000.00
THC balance_sheet (quarterly, 2025-12-31) — Net PPE: 7449000000.00
THC cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -972000000.00
THC cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -344000000.00
THC balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -8326000000.00
THC balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -8326000000.00
THC balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 203000000.00
THC balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 203000000.00
THC balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 84000000.00
THC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 84000000.00
THC balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 240000000.00
THC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 240000000.00